Alex Sinclair is the most eminent CSO of any ASX pharma below 500 million market cap. She is the key KOL in the IHH space and has clinical experience. I cannot think of another CSO in any pre revenue pharma who runs the biggest clinic in the world in their specialist disease area.
I think that Tom Duthey is excellent and the IR of the company is clear, concise and considered and as good or better than any microcap pharma on the ASX.
What is IXC Management doing well ?, page-3
-
- There are more pages in this discussion • 24 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IXC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.960M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 100000 | 6.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.8¢ | 10000 | 1 |
View Market Depth
| Last trade - 16.12pm 12/07/2024 (20 minute delay) ? |
| IXC (ASX) Chart |
Day chart unavailable